Alicja Copik’s story about natural cancer-killing cells illustrates one of the paths university research can take to the marketplace where it can change lives.

Cancer-fighting Technology Developed at UCF Licensed to French Pharmaceutical Giant

By: Zenaida Gonzalez Kotala on

One of the biggest pharma companies in the world will use a nanoparticle technology developed at UCF in hopes of coming up with new blood cancer treatments.

In May,  a cell-based cancer immunotherapy that utilizes a nanoparticle developed at UCF to stimulate a patient’s natural cancer-killing cells headed to Phase II clinical trial.

College of Medicine Associate Professor Alicja Copik and her team developed the technique in 2016 and then co-founded the company CytoSen to take the concept to market. In 2019, the company was acquired by Netherlands-based bio-pharmaceutical firm Kiadis Pharma, which saw the potential to develop new treatment options for cancer patients.

Last week, Kiadis licensed a bundle of technologies – including the one developed at UCF – to Sanofi in a deal estimated at about $1 billion. If the technologies advance through clinical trials and are approved, royalties would follow from commercial sales of products on the market.

Sanofi is based in France and employs more than 100,000 people in 100 countries. The company has 91 products in clinical trials. In 2019, it was ranked the eighth largest pharma company in the world based on sales of about $27.7 billion.

“The licensing of Kiadis’ CD38KO K-NK cells is particularly exciting for Sanofi since we will be studying this cell-based therapeutic with our recently FDA-approved treatment for patients with difficult-to-treat multiple myeloma, in hopes of bringing even more options to these patients with this hematologic cancer,” John Reed, the global head of research for Sanofi, says in a press release. “At Sanofi, we are committed to pioneering treatments that address unmet healthcare challenges. Innovative collaborations, such as this partnership with Kiadis, have the potential to expand the clinical benefits of our medicines by combining them with synergistic partnered therapeutics to deliver improved outcomes for patients.”

Natural killer (NK) cells are part of the body’s defense system and act as an army to protect us from invaders such as viruses and infections. Copik discovered a way to make NK cells even more powerful – by stimulating them with nanoparticles that multiply them and heighten their killing ability – and then use the cells to fight cancer. “That’s what it is all about,” she says, “giving patients a fighting chance of cancer survival.”

Copik’s story about natural cancer-killing cells illustrates one of the paths university research can take to the marketplace where it can change lives. This is why universities invest in Technology Transfer Offices that help innovations get patented and licensed to industry. The commercialization process can take years.

“Our office is grateful to have the unique opportunity to partner with industry to bring the most promising technological advances developed by our dedicated researchers to market to impact global healthcare and improve quality of life,” says Svetlana Shtrom, UCF’s director of Office of Technology Transfer.

Share This Article

Featured Content image

UCF Researchers Eagerly Awaiting First James Webb Space Telescope Images

UCF physics graduate student Olga Harrington Pinto is counting down the minutes until July 12. She is one of eight UCF researchers and one alumna who will be using the...

Read More

Featured Content image

UCF Hospitality Researchers’ Expertise Is Tapped for Global Sustainable Tourism Report

University of Central Florida hospitality researchers have co-authored an international report that identifies ways to ensure sustainable coastal and marine tourism around the globe. These include a renewed focus on stimulating new...

Read More

Featured Content image

The Performing Arts at UCF Empowers Community Members Living with Aphasia

A partnership between the School of Performing Arts, the School of Communication Sciences and Disorders, and the Department of Psychology at UCF is helping improve the lives of people living...

Read More

Featured Content image

UCF Signs Educational Partnership Agreement with U.S. Space Force

UCF, the nation’s Space University, has now entered an agreement with the U.S. Space Force to help develop technology and an agile workforce ready for space. The two organizations recently...

Read More